Výsledky vyhledávání

VA-ECMO and VV-ECMO in COVID-19: Severe ARDS or Cardiogenic Shock?

Autor: F Gatta, C Evans, N Lazarus

Publikováno v: American Journal of Cardiovascular and Thoracic Surgery. 5:1-7

The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, on December 2019. Since then it has spread worldwide, causing an unforeseen global crisis. Respiratory involvement ranging from a mild flu-lik

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3a849f1a368d8593c200d33171e22952
https://doi.org/10.15226/2573-864x/5/2/00169

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

28 Diagnosed vs Undiagnosed Chronic Obstructive Pulmonary Disease: Short and Long-term Impact on Coronary Artery Bypass Surgery

Autor: F Gatta, Mahmoud Loubani, Y Haqzad

Publikováno v: British Journal of Surgery. 108

Introduction This study sought to compare clinical outcomes among non-COPD, diagnosed COPD, and undiagnosed COPD patients, in CABG surgery. Method A single-centred retrospective study, from January 2010 to December 2019. Primary outcomes were post-op

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::27bf36eba398e26819f5dbb4ee8b0331
https://doi.org/10.1093/bjs/znab134.016

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trials

Autor: F Gatta, Salvatore Siena, Guy Hechmati, Reija Koukakis

Publikováno v: Quality of Life Research

Purpose Epidermal growth factor receptor inhibitors such as panitumumab are associated with characteristic skin toxicities. We summarise data from three panitumumab clinical trials to investigate the potential impact of skin toxicity on quality of li

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1bff06a72e2a4bd809b1301e0bdad09
http://europepmc.org/articles/PMC5010834

Zobrazit plný text záznamu

Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors

Autor: F Gatta, Stacey Harrelson, Yi Qian, Ateesha F. Mohamed, Juan Marcos Gonzalez, Jorge Arellano, Cynthia Campbell-Baird, A. Brett Hauber, Guy Hechmati

Publikováno v: The Patient

Background Bone-targeted agents (BTAs) used for the prevention of skeletal-related events (SREs) associated with metastatic bone disease possess different attributes that factor into treatment decisions. Objective The aim of this study was to evaluat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79501f64aee673ce18e5e953fe3a3513
https://doi.org/10.1007/s40271-015-0158-4

Zobrazit plný text záznamu

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe

Autor: F Gatta, Jean-Jacques Body, A. Rider, Yi Qian, Pamela Hallworth, Guy Hechmati, Debajyoti Bhowmik, Roger von Moos

Publikováno v: Journal of Bone Oncology
Journal of Bone Oncology, 14
Journal of Bone Oncology, Vol 14, Iss, Pp-(2019)

Background: Bone metastases (BMs) are common in patients with prostate cancer and can lead to skeletal-related events (SREs), which are associated with increased pain and reduced quality of life (QoL). Bone-targeted agents (BTAs), such as zoledronic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7390ea2f90f41c7dc689670d8f880926
https://pubmed.ncbi.nlm.nih.gov/30627511

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání